vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and TOMPKINS FINANCIAL CORP (TMP). Click either name above to swap in a different company.

TOMPKINS FINANCIAL CORP is the larger business by last-quarter revenue ($194.8M vs $104.5M, roughly 1.9× Immunocore Holdings plc). On growth, TOMPKINS FINANCIAL CORP posted the faster year-over-year revenue change (152.7% vs 24.3%). TOMPKINS FINANCIAL CORP produced more free cash flow last quarter ($31.9M vs $-35.5M). Over the past eight quarters, TOMPKINS FINANCIAL CORP's revenue compounded faster (63.6% CAGR vs 21.7%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Tompkins Financial Corporation is a small, diversified financial services company based in Ithaca, New York. It is the parent of the Tompkins Trust Company, as well as several other banks, an insurance agency, and a wealth management division.

IMCR vs TMP — Head-to-Head

Bigger by revenue
TMP
TMP
1.9× larger
TMP
$194.8M
$104.5M
IMCR
Growing faster (revenue YoY)
TMP
TMP
+128.4% gap
TMP
152.7%
24.3%
IMCR
More free cash flow
TMP
TMP
$67.5M more FCF
TMP
$31.9M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
TMP
TMP
Annualised
TMP
63.6%
21.7%
IMCR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
TMP
TMP
Revenue
$104.5M
$194.8M
Net Profit
$96.2M
Gross Margin
97.4%
Operating Margin
-18.8%
71.7%
Net Margin
49.4%
Revenue YoY
24.3%
152.7%
Net Profit YoY
388.9%
EPS (diluted)
$-0.61
$6.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
TMP
TMP
Q4 25
$104.5M
$194.8M
Q3 25
$103.7M
$87.4M
Q2 25
$98.0M
$82.6M
Q1 25
$93.9M
$81.7M
Q4 24
$84.1M
$77.1M
Q3 24
$80.2M
$76.6M
Q2 24
$75.4M
$72.7M
Q1 24
$70.5M
$72.8M
Net Profit
IMCR
IMCR
TMP
TMP
Q4 25
$96.2M
Q3 25
$-177.0K
$23.7M
Q2 25
$-10.3M
$21.5M
Q1 25
$5.0M
$19.7M
Q4 24
$19.7M
Q3 24
$8.7M
$18.6M
Q2 24
$-11.6M
$15.7M
Q1 24
$-24.4M
$16.9M
Gross Margin
IMCR
IMCR
TMP
TMP
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
IMCR
IMCR
TMP
TMP
Q4 25
-18.8%
71.7%
Q3 25
-6.9%
35.6%
Q2 25
-15.2%
34.2%
Q1 25
-3.9%
31.6%
Q4 24
-23.1%
33.4%
Q3 24
-10.6%
32.0%
Q2 24
-21.2%
28.3%
Q1 24
-37.6%
30.4%
Net Margin
IMCR
IMCR
TMP
TMP
Q4 25
49.4%
Q3 25
-0.2%
27.1%
Q2 25
-10.5%
26.0%
Q1 25
5.4%
24.1%
Q4 24
25.5%
Q3 24
10.9%
24.3%
Q2 24
-15.4%
21.6%
Q1 24
-34.7%
23.2%
EPS (diluted)
IMCR
IMCR
TMP
TMP
Q4 25
$-0.61
$6.72
Q3 25
$0.00
$1.65
Q2 25
$-0.20
$1.50
Q1 25
$0.10
$1.37
Q4 24
$-0.47
$1.39
Q3 24
$0.17
$1.30
Q2 24
$-0.23
$1.10
Q1 24
$-0.49
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
TMP
TMP
Cash + ST InvestmentsLiquidity on hand
$864.2M
$132.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$381.0M
$938.4M
Total Assets
$1.1B
$8.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
TMP
TMP
Q4 25
$864.2M
$132.8M
Q3 25
$892.4M
$193.5M
Q2 25
$882.8M
$212.6M
Q1 25
$837.0M
$193.1M
Q4 24
$820.4M
$134.4M
Q3 24
$901.3M
$132.3M
Q2 24
$859.6M
$70.9M
Q1 24
$832.8M
$57.1M
Total Debt
IMCR
IMCR
TMP
TMP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
TMP
TMP
Q4 25
$381.0M
$938.4M
Q3 25
$396.6M
$788.8M
Q2 25
$388.5M
$761.8M
Q1 25
$378.5M
$741.4M
Q4 24
$360.7M
$713.4M
Q3 24
$377.8M
$719.9M
Q2 24
$359.1M
$674.6M
Q1 24
$359.5M
$667.9M
Total Assets
IMCR
IMCR
TMP
TMP
Q4 25
$1.1B
$8.7B
Q3 25
$1.1B
$8.5B
Q2 25
$1.1B
$8.4B
Q1 25
$1.0B
$8.2B
Q4 24
$1.0B
$8.1B
Q3 24
$1.1B
$8.0B
Q2 24
$1.0B
$7.9B
Q1 24
$994.0M
$7.8B
Debt / Equity
IMCR
IMCR
TMP
TMP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
TMP
TMP
Operating Cash FlowLast quarter
$-32.7M
$38.9M
Free Cash FlowOCF − Capex
$-35.5M
$31.9M
FCF MarginFCF / Revenue
-34.0%
16.4%
Capex IntensityCapex / Revenue
2.8%
3.6%
Cash ConversionOCF / Net Profit
0.40×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$105.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
TMP
TMP
Q4 25
$-32.7M
$38.9M
Q3 25
$-4.5M
$34.9M
Q2 25
$26.0M
$18.9M
Q1 25
$435.0K
$22.2M
Q4 24
$-14.0M
$95.0M
Q3 24
$21.1M
$21.2M
Q2 24
$23.5M
$27.3M
Q1 24
$-4.6M
$23.2M
Free Cash Flow
IMCR
IMCR
TMP
TMP
Q4 25
$-35.5M
$31.9M
Q3 25
$-5.2M
$33.9M
Q2 25
$25.6M
$18.3M
Q1 25
$137.0K
$20.9M
Q4 24
$-17.5M
$88.8M
Q3 24
$20.3M
$18.9M
Q2 24
$23.1M
$26.3M
Q1 24
$-5.0M
$21.9M
FCF Margin
IMCR
IMCR
TMP
TMP
Q4 25
-34.0%
16.4%
Q3 25
-5.0%
38.8%
Q2 25
26.1%
22.1%
Q1 25
0.1%
25.5%
Q4 24
-20.9%
115.1%
Q3 24
25.3%
24.7%
Q2 24
30.7%
36.2%
Q1 24
-7.1%
30.0%
Capex Intensity
IMCR
IMCR
TMP
TMP
Q4 25
2.8%
3.6%
Q3 25
0.7%
1.1%
Q2 25
0.4%
0.8%
Q1 25
0.3%
1.7%
Q4 24
4.3%
8.1%
Q3 24
1.0%
2.9%
Q2 24
0.4%
1.3%
Q1 24
0.6%
1.9%
Cash Conversion
IMCR
IMCR
TMP
TMP
Q4 25
0.40×
Q3 25
1.47×
Q2 25
0.88×
Q1 25
0.09×
1.13×
Q4 24
4.82×
Q3 24
2.42×
1.14×
Q2 24
1.74×
Q1 24
1.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons